Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development

被引:21
作者
Hashimoto, S
Nishizumi, H
Hayashi, R
Tsuboi, A
Nagawa, F
Takemori, T
Sakano, H
机构
[1] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan
[2] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan
关键词
3 ' enhancer; B cell development; Ets family protein; Ig kappa gene; PU.1;
D O I
10.1093/intimm/11.9.1423
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During the development of lymphocytes, expression of the Ig genes is strictly regulated in a tissue-specific manner and in a time-ordered fashion. We have previously shown that the PU.1 binding motif in the Ig kappa 3' enhancer (kappa E3') and a novel Ets family protein other than PU.1 may be possibly involved in the control of V-kappa-J(kappa) joining. In the attempt to isolate the novel Ets family protein, we have screened cDNA libraries with the yeast one-hybrid method and identified a new PU.1-related factor, Prf, This novel Ets family protein is shown to interact with the PU.1 binding sequences in various promoters and enhancers, including kappa E3', It was found that expression of the prf gene is predominant in the B-lineage cells, with the exception of immature a cells. Since Prf does not exhibit functions of transcriptional activity, this novel protein may act as an antagonist against other Ets family proteins, e.g. PU.1 and Spi-B, Possible roles of Prf with respect to the B cell differentiation are discussed.
引用
收藏
页码:1423 / 1429
页数:7
相关论文
共 33 条
[11]   FUSION OF PDGF RECEPTOR-BETA TO A NOVEL ETS-LIKE GENE, TEL, IN CHRONIC MYELOMONOCYTIC LEUKEMIA WITH T(512) CHROMOSOMAL TRANSLOCATION [J].
GOLUB, TR ;
BARKER, GF ;
LOVETT, M ;
GILLILAND, DG .
CELL, 1994, 77 (02) :307-316
[12]  
Hayashi R, 1997, J IMMUNOL, V159, P4145
[13]  
Heydemann A, 1996, MOL CELL BIOL, V16, P1676
[14]   The 3' enhancer region determines the B/T specificity and pro-B pre-B specificity of immunoglobulin V-kappa-J(kappa) joining [J].
Hiramatsu, R ;
Akagi, K ;
Matsuoka, M ;
Sakumi, K ;
Nakamura, H ;
Kingsbury, L ;
David, C ;
Hardy, RR ;
Yamamura, K ;
Sakano, H .
CELL, 1995, 83 (07) :1113-1123
[15]   THE MACROPHAGE AND B-CELL SPECIFIC TRANSCRIPTION FACTOR PU.1 IS RELATED TO THE ETS ONCOGENE [J].
KLEMSZ, MJ ;
MCKERCHER, SR ;
CELADA, A ;
VANBEVEREN, C ;
MAKI, RA .
CELL, 1990, 61 (01) :113-124
[16]   A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex [J].
Kodandapani, R ;
Pio, F ;
Ni, CZ ;
Piccialli, G ;
Klemsz, M ;
McKercher, S ;
Maki, RA ;
Ely, KR .
NATURE, 1996, 380 (6573) :456-460
[17]   IDENTIFICATION OF ETS-RELATED AND NOTCH-RELATED SUBUNITS IN GA BINDING-PROTEIN [J].
LAMARCO, K ;
THOMPSON, CC ;
BYERS, BP ;
WALTON, EM ;
MCKNIGHT, SL .
SCIENCE, 1991, 253 (5021) :789-792
[18]   PROTEIN-BINDING SITES IN IG GENE ENHANCERS DETERMINE TRANSCRIPTIONAL ACTIVITY AND INDUCIBILITY [J].
LENARDO, M ;
PIERCE, JW ;
BALTIMORE, D .
SCIENCE, 1987, 236 (4808) :1573-1577
[19]   Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities [J].
McKercher, SR ;
Torbett, BE ;
Anderson, KL ;
Henkel, GW ;
Vestal, DJ ;
Baribault, H ;
Klemsz, M ;
Feeney, AJ ;
Wu, GE ;
Paige, CJ ;
Maki, RA .
EMBO JOURNAL, 1996, 15 (20) :5647-5658
[20]   THE OPTIMALITY OF CONSUMER STOCKPILING STRATEGIES [J].
MEYER, RJ ;
ASSUNCAO, J .
MARKETING SCIENCE, 1990, 9 (01) :18-41